Institutional Biosafety Committee – IBC

The Institutional Biosafety Committee (IBC) reviews research and teaching activities that involve recombinant DNA (rDNA), biological agents or toxins. The purpose of the IBC review process is to ensure that University activities comply with government regulations (see NIH and CDC links below) and provide appropriate safeguards for human health and the environment. The IBC consists of University faculty and community representatives. The committee meets quarterly to review faculty research proposals and biosafety issues at the University.

For information or assistance with research activities, please contact the Biological Safety Officer or the IBC Chairperson.

Recommended Links

• NIH Office of Biotechnology Activities
  • NIH Guidelines for Research Involving Recombinant DNA Molecules
• Biosafety in Microbiological and Biomedical Laboratories (CDC/NIH)